Showing results (11-20 of 60) with videos related to
Sort By:
Pageof 6
Legal Medicine (Tokyo, Japan)|September 15, 2004
Involvement of inducible nitric oxide synthase in renal failure after mild hemorrhageToshiko Tanaka, Hiroaki Sato, Toshiro Kita, et al.Burns : Journal of the International Society for Burn Injuries|March 5, 2003
Escherichia coli endotoxin enhances acute renal failure in rats after thermal injuryHiroki Yamaguchi, Toshiro Kita, Hiroaki Sato, et al.International Journal of Oncology|August 12, 2014
Relative expression of hMena11a and hMenaINV splice isoforms is a useful biomarker in development and progression of human breast carcinomaNoriyuki Tanaka, Hiroshi Yoshida, Yoshio Suzuki, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 30, 2008
Role of tumor necrosis factor-alpha and interleukin-1beta on lung dysfunction following hemorrhagic shock in ratsHiroaki Sato, Kentaro Kasai, Toshiko Tanaka, et al.Journal of Forensic Sciences|September 8, 2009
Unexpected death in elephantiasis due to an abnormal life-styleHiroaki Sato, Toshiko Tanaka, Kentaro Kasai, et al.Forensic Science International. Genetics|December 17, 2008
Morphological study of fragmented DNA on touched objectsToshiro Kita, Hiroki Yamaguchi, Mitsuru Yokoyama, et al.Legal Medicine (Tokyo, Japan)|October 16, 2009
A study of neutrophil as a morphological marker of death from hemorrhagic shock in forensic practice casesHiroaki Sato, Toshiro Kita, Toshiko Tanaka, et al.International Journal of Experimental Pathology|November 30, 2004
The role of tumour necrosis factor-alpha in renal dysfunction following mild haemorrhage in ratsHiroaki Sato, Toshiko Tanaka, Toshiro Kita, et al.Shock (Augusta, Ga.)|October 26, 2005
Role of p38 mitogen-activated protein kinase on renal dysfunction after hemorrhagic shock in ratsHiroaki Sato, Toshiko Tanaka, Kentaro Kasai, et al.European Neurology|January 25, 2014
Low frontal assessment battery score as a risk factor for falling in patients with Hoehn-Yahr Stage III Parkinson's disease: a 2-year prospective studyHiroshi Kataoka, Noriyuki Tanaka, Keigo Saeki, et al.Pageof 6